Insys gets more analyst love, shares jump

|About: Insys Therapeutics, Inc. (INSY)|By:, SA News Editor

Wells Fargo starts Insys (INSY +5.9%) at Outperform (PT $19-21). Oppenheimer also initiated coverage today.

Analyst Michael Faerm thinks Subsys "is at the early stages of a multiyear organic growth ramp."

The technology used in Subsys (a sublingual spray) "can potentially be leveraged into longer term pipeline candidates."